These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Immunologic considerations for the development of conjugate vaccines. Garner CV; Pier GB Contrib Microbiol Immunol; 1989; 10():11-7. PubMed ID: 2510971 [No Abstract] [Full Text] [Related]
11. Laboratory studies on oxacillin. I. In vitro activity against staphylococci and some other bacterial pathogens. II. Absorption and urinary excretion in normal young men. KLEIN JO; SABATH LD; FINLAND M Am J Med Sci; 1963 Apr; 245():399-412. PubMed ID: 14033374 [No Abstract] [Full Text] [Related]
12. Different meningitis-causing bacteria induce distinct inflammatory responses on interaction with cells of the human meninges. Fowler MI; Weller RO; Heckels JE; Christodoulides M Cell Microbiol; 2004 Jun; 6(6):555-67. PubMed ID: 15104596 [TBL] [Abstract][Full Text] [Related]
14. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development. Jennings HJ Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499 [No Abstract] [Full Text] [Related]
15. [Identification of Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis by polymerase chain reaction]. Parra E; Castañeda E; Moreno J Biomedica; 2007 Sep; 27(3):454-60. PubMed ID: 18320111 [TBL] [Abstract][Full Text] [Related]
16. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. Campbell H; Byass P; Ahonkhai VI; Vella PP; Greenwood BM Pediatrics; 1990 Jul; 86(1):102-7. PubMed ID: 2113671 [TBL] [Abstract][Full Text] [Related]
17. Microbiologic effect of bovine cerebrospinal fluid and azithromycin against Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. Destache CJ; Pakiz CB; Kersting K Pharmacotherapy; 1997; 17(5):985-9. PubMed ID: 9324186 [TBL] [Abstract][Full Text] [Related]
18. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Dashefsky B; Wald E; Guerra N; Byers C Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519 [TBL] [Abstract][Full Text] [Related]
19. Use of animal testing for evaluating glycoconjugate vaccine immunogenicity. Madore DV; Strong N; Eby R Dev Biol Stand; 1999; 101():49-56. PubMed ID: 10566775 [TBL] [Abstract][Full Text] [Related]
20. Contemporary trends in conjugate vaccine development. Cruse JM; Lewis RE Contrib Microbiol Immunol; 1989; 10():1-10. PubMed ID: 2510970 [No Abstract] [Full Text] [Related] [Next] [New Search]